🇺🇸 FDA
Patent

US 11957687

Modulators of HSD17B13 and methods of use thereof

granted A61KA61K31/4412A61K31/4427

Quick answer

US patent 11957687 (Modulators of HSD17B13 and methods of use thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Apr 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/4412, A61K31/4427, A61K31/443, A61K31/4433